Antioxidant Status in STZ-induced diabetic rats treated with Vanadium pentoxide nanoparticles
Loading...
Date
2019-12
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Antioxidant status determines the susceptibility of tissues to the oxidative stress associated with diabetes and its complications;
hence in the present study antioxidant status was explored in streptozotocin-induced diabetic rats treated with vanadium in
the form of vanadium pentoxide nanoparticles. Vanadium pentoxide and vanadium pentoxide nanoparticles at the dose rate
of 5mg/kg were administered orally in STZ (50mg/Kg) induced diabetic rats for 30 days and glimepiride (reference drug)
was administered orally at the dose rate of 800 μg/kg body weight. Vanadium pentoxide nanoparticles significantly reduced
the blood glucose levels than the diabetic control and other treatment group of rats. On exploration of antioxidant status in
liver, kidney and pancreas tissues, vanadium in the form of vanadium pentoxide nanoparticles outperformed the vanadium
pentoxide by increasing the activities of the enzymes catalase, superoxide dismutase and glutathione peroxidase, and the
concentration of reduced glutathione and by decreasing the lipid peroxide levels. The present study also showed that the
restoration of antioxidant status by vanadium pentoxide nanoparticles is comparable with that of the reference drug. It can
be concluded that vanadium pentoxide nanoparticles, due to its superior control over hyperglycemia and antioxidant
properties, outperformed the vanadium pentoxide treatment in enhancing the antioxidant status in diabetic rats.
Description
TNV_IJAR_2019_52(12)1594-1598
Keywords
Veterinary Science